Skip to content
OpenCapital
Get started

Ingersoll Rand IR Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Service10%0.0%

Other financials

Income statement

See full
Revenue$1.8B+7.6%
Gross profit$792.4M+3.5%
Operating income$289.7M-4.2%
Net income$192.1M+3.0%
EPS (diluted)$0.49+6.5%

Balance sheet

See full
Cash & equivalents$1.3B-21.0%
Total debt$4.8B+0.2%
Total equity$10.2B-3.0%
Total assets$18.2B-0.9%

Cash flow

See full
Operating cash flow$199.7M-22.1%
CapEx$36.3M+7.7%
Free cash flow$163.4M-26.6%

Valuation

See full
Market cap$31.84B-9.3%
Enterprise value$35.41B-8.4%
P/E54.3×-12.9×
P/S4.1×-0.7×

Profitability

See full
Gross margin43.2%-0.6pp
Operating margin14.5%-3.4pp
Net margin7.5%-3.8pp
FCF margin14.9%-3.9pp

Returns & leverage

See full
Return on equity5.7%-2.4pp
Debt / equity0.5×0.0×
Current ratio2.2×-0.2×